Localisation of neuroendocrine tumours of the upper gastrointestinal tract.
Open Access
- 1 April 1994
- Vol. 35 (4) , 471-475
- https://doi.org/10.1136/gut.35.4.471
Abstract
In order to localise neuroendocrine tumours of the foregut type (that is, of the stomach, duodenum, and pancreas), 18 patients were studied prospectively by endoscopic ultrasonography, computed tomography, transabdominal ultrasonography, magnetic resonance imaging, and somatostatin receptor scintigraphy. These 18 patients had a total of 25 primary tumour lesions which were verified histologically in tissue obtained by surgery or by ultrasound or endoscopy guided biopsy. Tumours were found in the stomach (n = 1), duodenum (n = 6), pancreas (n = 17), and liver (n = 1). Endoscopic ultrasonography had the highest sensitivity for tumour detection, followed by somatostatin receptor scintigraphy, computed tomography, transabdominal ultrasonography, and magnetic resonance imaging (88%, 52%, 36%, 32%, and 24% respectively). Endoscopic ultrasonography was especially sensitive in tumours smaller than 2 cm in diameter (88% v somatostatin receptor scintigraphy 35%; computed tomography 12%; transabdominal ultrasonography 6%; and magnetic resonance imaging 0%). Of 17 tumours located in the pancreas, endoscopic ultrasonography showed a sensitivity of 94% (somatostatin receptor scintigraphy 47%; computed tomography 47%; transabdominal ultrasonography 41%; and magnetic resonance imaging 29%). Of eight extrapancreatic tumours, six were identified by endoscopic ultrasonography, five by somatostatin receptor scintigraphy, and only one by computed tomography, transabdominal ultrasonography, and magnetic resonance imaging. One neuroendocrine tumour that was not detected by endoscopic ultrasonography was correctly identified by somatostatin receptor scintigraphy. Endoscopic ultrasound allowed correct determination of the tumour size and tumour spread into parapancreatic structures, especially the large vessels (T stage), in all 14 patients operated upon. The lymph node stage (N stage) was correctly determined in 10 of these 14 patients. In summary, endoscopic ultrasonography and somatostatin receptor scintigraphy were the most sensitive imaging methods for the localisation of these tumours and should be used as early diagnostic procedures to accurately stage neuroendocrine tumours of the foregut type.Keywords
This publication has 27 references indexed in Scilit:
- Localization of Pancreatic Endocrine Tumors by Endoscopic UltrasonographyNew England Journal of Medicine, 1992
- Endosonographisches Staging des PankreaskarzinomsDeutsche Medizinische Wochenschrift (1946), 1992
- Endoscopic ultrasound for localisation of islet cell tumours.Gut, 1992
- Localization of endocrine tumors of the pancreas with endoscopic ultrasonographyCancer, 1991
- Gastrinomas in the Duodenums of Patients with Multiple Endocrine Neoplasia Type 1 and the Zollinger-Ellison SyndromeNew England Journal of Medicine, 1990
- Value of tumor localization in patients with insulinomaWorld Journal of Surgery, 1990
- The diagnosis of pancreatic cancer by endoscopic ultrasonographyGastrointestinal Endoscopy, 1988
- Prospective Study of Gastrinoma Localization and Resection in Patients with Zollinger-Ellison SyndromeAnnals of Surgery, 1986
- Endoscopic Ultrasonography in Analysing Peri-Intestinal Lymph Node Abnormality: Preliminary Results of Studies in Vitro and in VivoScandinavian Journal of Gastroenterology, 1986
- Decreasing Incidence of Gallstone Disease in a Defined Swedish PopulationScandinavian Journal of Gastroenterology, 1985